CNS drug development

Boston, USA & Shanghai, China – March 9, 2026 Rapport Therapeutics and Tenacia Biotechnology have announced a strategic collaboration...

MILWAUKEE, Feb. 22, 2026 — New clinical research presented at the 2026 Annual Meeting of the American Academy of...

WASHINGTON, Feb. 20, 2026 — Vanda Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has approved BYSANTI™...

BOSTON, Feb. 20, 2026 — Seaport Therapeutics announced new findings from a comprehensive meta-analysis examining how clinical trial design...

MOUNTAIN VIEW, Calif., Feb. 13, 2026 — Alto Neuroscience announced completion of patient enrollment in its Phase 2 proof-of-concept...

Boston, Massachusetts — November 19, 2025 — Beacon Biosignals has announced a multi-year expansion of its strategic collaboration with...

BOSTON, MA — November 18, 2025 — Emulate, Inc. has announced the launch of its next-generation Brain-Chip R1, a...